Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Rutgers, The State University of New Jersey
ClinicalTrials.gov Identifier:
NCT00667641
First received: April 25, 2008
Last updated: May 9, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)